Clinical Trial

Efficacy and Safety of Single-port Surgical Robot System in Thoraic Surgery

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 29, 2024 (before its estimated July 15, 2025 completion). Its status may not reflect the trial's current state.
Summary
Robotic surgical systems have become a promising surgical assistance system, with unique advantages such as 3D high-definition visual system, highly flexible wrist-jointed instruments, and automatic fitering of hand tremors. Robotic surgical systems is applied in various fields including urology, general surgery, cardiothoracic surgery, head and neck surgery, and gynecology. Currently, the Da Vinci surgical robot system is the most widely used robot system globally. However, the Da Vinci robot system for single-port laparoscopic surgery has not yet been launched in China. Therefore, the investigators conduct a prespective, single-center study to evaluate the efficacy and safety of single-port surgical robot system in thoracic surgery.
Trial Details
NCT Number NCT06286150
Lead Sponsor The First Affiliated Hospital of Guangzhou Medical University
Conditions Lung Cancer
Enrollment 20 participants
Start Date 2023-09-15
Primary Completion 2025-07-15 (estimated)
Study Completion 2027-07-15 (estimated)
Updated on ClinicalTrials.gov 2024-02-29